Thanks for the breakdown n1sp even if assuming...

Quote:

---

Assuming 10% of average volume is warrant-shares being sold, the total number of warrant-shares sold during this period is ~23M shares leaving ~36.5M warrant-shares to be sold (original issued holders).

Adding in the 29,357,527 (~29.4M) warrant-shares issued during the 'subsequent event' period brings total warrant-shares to be sold to ~65.9M

Total volume traded from 3-27-20 thru 4-9-20 (10 trading days) is 165,896,185 shares. Average daily volume in this period is ~16.6M shares.

Again assuming 10%..., the total number of warrant-shares sold during this period is 16.6M shares leaving ~49.3M warrant-shares to be sold.

---

Read More: https://investorshangout.com/post/newpost/60551?
replyto=5730907#ixzz6JDrgH8z8

While I realize some have been holding a long time waiting for the day... before no one expected this turn of events with Covid-19... so wondering why investors or even traders wouldn't just hold a little longer as the potential of CYDY could now very well be exponential (or will they be the ones buying much more... even if at higher cost... and bringing the pps to heights never imagined before?).

In any case, I'm excited for the days and future ahead for CytoDyn/Leronlimab ... best part to say this is the company that saved lives.


Hope all are having a good holiday weekend... stay safe!